Numerical calculation of the radiofrequency transfer function of cochlear implants for assessing deposited power in MRI.


Journal

Physics in medicine and biology
ISSN: 1361-6560
Titre abrégé: Phys Med Biol
Pays: England
ID NLM: 0401220

Informations de publication

Date de publication:
04 09 2020
Historique:
pubmed: 25 6 2020
medline: 6 11 2020
entrez: 25 6 2020
Statut: epublish

Résumé

The medical imaging of patients with a cochlear implant inside a Magnetic Resonance Imaging (MRI) scanner carries the risk of power deposition in the tissues at the tip of the implant lead, which may result in their heating. In order to assess this risk, ISO/TS 10 974 (2018) describes a methodology (Tier 3 approach) whereby a radiofrequency electrical model for the implant lead in the form of a transfer function is constructed. The construction of the transfer function takes place by assuming that a homogenous medium surrounds the implant, whereas, in reality, implants can traverse various tissues of different electrical properties. The results show that the use of a High Permittivity Medium (HPM) overestimates the Tier 3 calculated deposited power by almost 6 dB, whereas a Low Permittivity Medium (LPM) underestimates it by 9 dB, compared to the in vivo power deposition in three virtual human models, obtained following the Tier 4 approach of ISO/TS 10 974(2018). Since the Tier 3 approach requires less computational resources compared to Tier 4, we suggest its modification with the use of two media (mixed media approach), where implant is immersed. By carefully choosing the media electrical properties, it is possible to calculate power deposition values at the lead tip that differ less than 1 dB from the in vivo ones.

Identifiants

pubmed: 32580168
doi: 10.1088/1361-6560/ab9fc7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

175005

Auteurs

George Tsanidis (G)

Department of Physics, Aristotle University of Thessaloniki, Thessaloniki, Greece. Thessaloniki Software Solutions (THESS) S.A., Technopolis ICT Business Park, Thessaloniki, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH